Patents by Inventor Neil H. Riordan
Neil H. Riordan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10172898Abstract: Compositions of matter, uses, and formulations of food supplements/nutrients capable of eliciting mobilization of various stem/progenitor cells, including hematopoietic stem cells and endothelial progenitor cells are disclosed. In one embodiment a formulation contains a mixture of ellagic acid, vitamin D3, beta 1,3 glucan and a ferment of the bacterium, Lactobacillus fermentum, with an extract of green tea, extract of goji berries, and extract of the root of astragalus added prior to fermentation. Said formulation, originally developed as an antioxidant/immune stimulator was found to have the unexpected property of eliciting stem/progenitor cell mobilization.Type: GrantFiled: December 9, 2010Date of Patent: January 8, 2019Inventor: Neil H. Riordan
-
Publication number: 20180221417Abstract: Disclosed are means, methods and compositions of matter for treatment of dry eye disease using factors released from placental amniotic tissue when cultured in a liquid media. In one embodiment of the invention amnion is extracted from a hemochorial placenta and cultured in a means to maintain viability of said amnion. Said means in which hemochorial placenta amnion is maintained viable is subsequently used to collect factors which are released by said placental amnion which are useful for treatment of dry eye disease either in unpurified form, in concentrated form, or specific molecular weight fractions derived thereof.Type: ApplicationFiled: February 7, 2018Publication date: August 9, 2018Applicant: Aidan Research and Consulting, LLCInventor: Neil H. Riordan
-
Publication number: 20170290863Abstract: The invention provides pluripotent stem cells and methods for making and using pluripotent stem cells. Pluripotent stem cells, among other things, can differentiate into various cell lineages in vitro, ex vivo and in vivo. Pluripotent stem cells, among other things, can also be used to produce conditioned medium.Type: ApplicationFiled: February 17, 2017Publication date: October 12, 2017Applicant: XON Cells, Inc.Inventors: Thomas E. Ichim, Xiaolong Meng, Neil H. Riordan
-
Publication number: 20160263162Abstract: Disclosed are methods, compositions of matter, and cells, useful for the treatment of autism, social integrative disorders, and various cognitive abnormalities. The invention discloses, inter alia, means of inducing angiogenesis and immune modulation either in sequence or parallel in order to substantially ameliorate or reverse the progression of autism. The use of stem cells, and cells naturally possessing or endowed with angiogenic and anti-inflammatory activity are disclosed for autism either alone or in combination with various therapeutic interventions.Type: ApplicationFiled: October 8, 2015Publication date: September 15, 2016Applicant: XON Cells, Inc.Inventors: Neil H. Riordan, Thomas E. Ichim
-
Publication number: 20160067213Abstract: Disclosed are methods, compositions of matter and cells for treatment of cardiovascular disease through concurrent inhibition of oxidative stress while administration of a cell therapy. The invention also concerts the modulation of oxidative stress for preferential induction of differentiation while concurrently inhibiting inflammatory processes that decrease efficacy of cellular therapy.Type: ApplicationFiled: November 18, 2015Publication date: March 10, 2016Applicant: Creative Medical Health Inc.Inventors: Tom E. Ichim, Neil H. Riordan, Fabio Solano Salazar
-
Publication number: 20160038542Abstract: Disclosed are methods, compositions, and cells useful for increasing insulin sensitivity, as well as lack of insulin production in a host in need thereof. One aspect of the invention discloses methods of increasing skeletal muscle perfusion through administration of cells capable of directly and/or indirectly stimulatory of angiogenesis and/or vascular responsiveness. Another aspect provides means of increasing sensitivity to insulin through administration of a cell composition capable of integrating into host insulin responsive tissue and upregulating responsiveness either through mobilization of host cells capable of responding to insulin, mobilization of host cells capable of endowing insulin responsiveness on other host cells, exogenously administered cells taking the role of insulin responsiveness, or exogenously administered cells endowing insulin responsiveness on other host cells.Type: ApplicationFiled: August 19, 2014Publication date: February 11, 2016Inventors: Neil H. Riordan, Tom Ichim
-
Publication number: 20150104470Abstract: Disclosed are compositions of matter, methods of treatment, and protocols useful for therapeutic immune modulation using cell therapy administered perilymphatically or intralymphatically. In one particular embodiment, the invention provides means of treating an autoimmune condition by perilymphatic administration of a mesenchymal stem cell population. Said mesenchymal stem cell populations may be derived from umbilical cord tissues such as the Wharton's Jelly, amniotic membranes, or amniotic stem cells. In another particular embodiment Sertoli cells may be utilized as immune modulatory cells for the practice of the invention.Type: ApplicationFiled: October 10, 2014Publication date: April 16, 2015Inventor: Neil H. Riordan
-
Publication number: 20150024483Abstract: Disclosed are therapeutic compositions useful for treatment of degenerative, autoimmune, inflammatory, and neurological conditions. In one embodiment, clinical conditions are treated by administration of a standardized composition of stem cell, progenitor cell, or cellular supernatant. The invention provides doses of conditioned media that mediate therapeutic effects at concentrations that would not be expected to produce biological effects.Type: ApplicationFiled: October 8, 2014Publication date: January 22, 2015Inventors: Neil H. Riordan, Jorge Paz Rodriguez
-
Patent number: 8895299Abstract: A method of increasing the growth of stem cells by mixing the stem cells with a growth medium that has been conditioned by an incubation with placental tissue. The method increases the expansion of the stem cell population.Type: GrantFiled: June 25, 2010Date of Patent: November 25, 2014Assignee: XON Cells, Inc.Inventor: Neil H. Riordan
-
Publication number: 20130251670Abstract: Described are methods of treating macular edema, as well as other complications of ocular inflammation, through the administration of various stem cell populations and conditioned media thereof. In one embodiment a patient suffering from macular edema is administered an intramuscular dose of media conditioned by placental mesenchymal stem cells at a sufficient concentration and frequency to elicit a reduction in ocular inflammation. Other embodiments of the invention teach intra-ocular, intravenous, sublingual, and oral means of delivery conditioned media from various stem cell populations that has been optimized for anti-inflammatory, regenerative, and immune modulatory properties.Type: ApplicationFiled: September 13, 2012Publication date: September 26, 2013Applicant: Aidan Products, IncInventors: Neil H. Riordan, Jorge Paz Rodriguez
-
Publication number: 20130156726Abstract: The invention provides pluripotent stem cells and methods for making and using pluripotent stem cells. Pluripotent stem cells, among other things, can differentiate into various cell lineages in vitro, ex vivo and in vivo. Pluripotent stem cells, among other things, can also be used to produce conditioned medium.Type: ApplicationFiled: June 15, 2012Publication date: June 20, 2013Applicant: MediStem Laboratories, Inc.Inventors: THOMAS E. ICHIM, XIAOLONG MENG, NEIL H. RIORDAN
-
Publication number: 20120276215Abstract: Disclosed are therapeutic compositions useful for treatment of degenerative, autoimmune, inflammatory, and neurological conditions. In one embodiment, clinical conditions are treated by administration of a standardized composition of stem cell, progenitor cell, or cellular supernatant. The invention provides doses of conditioned media that mediate therapeutic effects at concentrations that would not be expected to produce biological effects.Type: ApplicationFiled: April 26, 2012Publication date: November 1, 2012Inventors: Neil H. Riordan, Jorge Paz Rodriguez
-
Publication number: 20120269774Abstract: Methods, cells, and compositions of matter are disclosed for performing stem cell transplants in patients that have not been previously immunosuppressed. Specific disclosed are methods of matching, methods of treating the stem cell graft, and use of engraftment-assisting cells and agents.Type: ApplicationFiled: September 20, 2007Publication date: October 25, 2012Applicant: MEDISTEM LABORATORIES, INCInventors: Thomas E. Ichim, Neil H. Riordan
-
Publication number: 20120195969Abstract: Disclosed are methods and compositions for treatment of acne or acneform conditions, particularly but not limited to, acne vulgaris with products generated from culture of stem or progenitor cells. Specifically, compositions of matter are disclosed which are useful for the treatment of acne and acne associated disease states, in particular acne vulgaris, by topical administration of products derived from stem cells or progenitor cells.Type: ApplicationFiled: September 29, 2011Publication date: August 2, 2012Applicant: AIDAN RESEARCH AND CONSULTING, LLCInventors: Neil H. Riordan, Tierney M. Riordan
-
Publication number: 20110135759Abstract: Compositions of matter, uses, and formulations of food supplements/nutrients capable of eliciting mobilization of various stem/progenitor cells, including hematopoietic stem cells and endothelial progenitor cells are disclosed. In one embodiment a formulation contains a mixture of ellagic acid, vitamin D3, beta 1,3 glucan and a ferment of the bacterium, Lactobacillus fermentum, with an extract of green tea, extract of goji berries, and extract of the root of astragalus added prior to fermentation. Said formulation, originally developed as an antioxidant/immune stimulator was found to have the unexpected property of eliciting stem/progenitor cell mobilization.Type: ApplicationFiled: December 9, 2010Publication date: June 9, 2011Applicant: Aidan Products, IncInventor: Neil H. Riordan
-
Publication number: 20110117650Abstract: A vessel is adapted to be used in a procedure for isolating and collecting cells from a tissue portion using a centrifuge by providing a sealable chamber separated into two sections by a mesh screen, the chamber having a conical bottom inner surface, with a port at the apex in the lowest point in the chamber and ports at the top of the chamber, the method including placing the tissue portion in the chamber above the screen, washing the tissue, repeatedly as needed, by introducing a washing solution through a top port and draining the wash solution from the chamber through the bottom port, introducing an enzyme solution through a top port, allowing the enzyme solution to partially digest the tissue, centrifuging the vessel, and draining the isolated cells through the bottom port.Type: ApplicationFiled: November 10, 2010Publication date: May 19, 2011Inventor: Neil H. Riordan
-
Publication number: 20110104100Abstract: Disclosed are methods, compositions of matter, and cells, useful for the treatment of autism, social integrative disorders, and various cognitive abnormalities. The invention discloses, inter alia, means of substantially ameliorating or reversing the progression of autism through the administration of autologous and/or allogeneic stem cells, alone or in combination with mobilization agents. The use of stem cells and cells naturally possessing or endowed with angiogenic and anti-inflammatory activity are disclosed for autism either alone or in combination with various therapeutic interventions.Type: ApplicationFiled: October 3, 2008Publication date: May 5, 2011Applicant: MEDISTEM LABORATORIES, INC.Inventors: Neil H. Riordan, Thomas E. Ichim
-
Publication number: 20100261152Abstract: A method of increasing the growth of stem cells by mixing the stem cells with a growth medium that has been conditioned by an incubation with placental tissue. The method increases the expansion of the stem cell population.Type: ApplicationFiled: June 25, 2010Publication date: October 14, 2010Applicant: MEDISTEM LABORATORIES, INC.Inventor: Neil H. Riordan
-
Patent number: 7749495Abstract: The invention relates to inducing an immune response toward tumor associated antigens and in particular to the administration of high molecular weight isolates of autologous urine either alone, with adjuvants, or with antigen presenting cells. The antigen presenting cells have been cocultured with isolates of autologous urine. The invention can also be used to treat cachexia in cancer or AIDS patients.Type: GrantFiled: May 23, 2008Date of Patent: July 6, 2010Assignee: Aidan, Inc.Inventor: Neil H. Riordan
-
Publication number: 20090291061Abstract: The present disclosure provides means of treating degenerated blood vessels through administration of stem cells or activators of stem cells. In one particular embodiment vessel reactivity is increased through administration of stem cells or stem cell activating compounds. Other embodiments include “reconditioning” of vessels prone to aneurysms, repairing aneurysms of vessels, or acceleration of endothelialization after stent placement. Provided within the invention are methods of rejuvenating properties of said vessels associated with physiological health, examples of which include appropriate production of anti-coagulating/clotting factors, control of angiogenesis, and appropriate revascularization of injured tissue.Type: ApplicationFiled: May 21, 2009Publication date: November 26, 2009Inventors: Neil H. Riordan, Thomas E. Ichim